{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:04:15Z","timestamp":1781712255001,"version":"3.54.5"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,10]]},"DOI":"10.7759\/cureus.96529","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T07:19:22Z","timestamp":1762845562000},"source":"Crossref","is-referenced-by-count":2,"title":["Prophylaxis of Preeclampsia With Low-Dose Aspirin: A Comprehensive Review"],"prefix":"10.7759","author":[{"given":"Hira","family":"Sohail","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.5468\/ogs.22261","article-title":"Preeclampsia and aspirin","volume":"66","author":"Ahn TG","year":"2023","unstructured":"Ahn TG, Hwang JY. Preeclampsia and aspirin. Obstet Gynecol Sci. 2023, 66:120-32. 10.5468\/ogs.22261","journal-title":"Obstet Gynecol Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/nu14102087","article-title":"An overview of obesity, cholesterol, and systemic inflammation in preeclampsia","volume":"14","author":"Alston MC","year":"2022","unstructured":"Alston MC, Redman LM, Sones JL. An overview of obesity, cholesterol, and systemic inflammation in preeclampsia. Nutrients. 2022, 14:14-6. 10.3390\/nu14102087","journal-title":"Nutrients"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.861245","article-title":"The inflammatory cytokine imbalance for miscarriage, pregnancy loss and COVID-19 pneumonia","volume":"13","author":"Vesce F","year":"2022","unstructured":"Vesce F, Battisti C, Crudo M. The inflammatory cytokine imbalance for miscarriage, pregnancy loss and COVID-19 pneumonia. Front Immunol. 2022, 13:861245. 10.3389\/fimmu.2022.861245","journal-title":"Front Immunol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.nwh.2017.12.002","article-title":"Low-dose aspirin for the prevention of preeclampsia","volume":"22","author":"Fantasia HC","year":"2018","unstructured":"Fantasia HC. Low-dose aspirin for the prevention of preeclampsia. Nurs Womens Health. 2018, 22:87-92. 10.1016\/j.nwh.2017.12.002","journal-title":"Nurs Womens Health"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-017-0757-7","article-title":"Pathophysiology and current clinical management of preeclampsia","volume":"19","author":"Amaral LM","year":"2017","unstructured":"Amaral LM, Wallace K, Owens M, LaMarca B. Pathophysiology and current clinical management of preeclampsia. Curr Hypertens Rep. 2017, 19:61. 10.1007\/s11906-017-0757-7","journal-title":"Curr Hypertens Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2025.101054","article-title":"Preeclampsia: insights into pathophysiological mechanisms and preventive strategies","volume":"23","author":"Martini C","year":"2025","unstructured":"Martini C, Saeed Z, Simeone P, et al.. Preeclampsia: insights into pathophysiological mechanisms and preventive strategies. Am J Prev Cardiol. 2025, 23:101054. 10.1016\/j.ajpc.2025.101054","journal-title":"Am J Prev Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13041022","article-title":"Aspirin at 75 to 81 mg daily for the prevention of preterm pre-eclampsia: systematic review and meta-analysis","volume":"13","author":"Demuth B","year":"2024","unstructured":"Demuth B, Pellan A, Boutin A, Bujold E, Ghesqui\u00e8re L. Aspirin at 75 to 81 mg daily for the prevention of preterm pre-eclampsia: systematic review and meta-analysis. J Clin Med. 2024, 13:14-6. 10.3390\/jcm13041022","journal-title":"J Clin Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01633.x","article-title":"Persistent production of platelet thromboxane A2 in patients chronically treated with aspirin","volume":"3","author":"Pulcinelli FM","year":"2005","unstructured":"Pulcinelli FM, Riondino S, Celestini A, Pignatelli P, Trifir\u00f2 E, Di Renzo L, Violi F. Persistent production of platelet thromboxane A2 in patients chronically treated with aspirin. J Thromb Haemost. 2005, 3:2784-9. 10.1111\/j.1538-7836.2005.01633.x","journal-title":"J Thromb Haemost"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2011.03943.x","article-title":"Anti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapy","volume":"72","author":"Warner TD","year":"2011","unstructured":"Warner TD, Nylander S, Whatling C. Anti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapy. Br J Clin Pharmacol. 2011, 72:619-33. 10.1111\/j.1365-2125.2011.03943.x","journal-title":"Br J Clin Pharmacol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-024-01623-9","article-title":"Clinical features of recurrent preeclampsia: a retrospective study of 109 recurrent preeclampsia patients","volume":"47","author":"Han S","year":"2024","unstructured":"Han S, Zhang H, He Y, Chen Q. Clinical features of recurrent preeclampsia: a retrospective study of 109 recurrent preeclampsia patients. Hypertens Res. 2024, 47:1410-9. 10.1038\/s41440-024-01623-9","journal-title":"Hypertens Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00055.2024","article-title":"Guidelines for assessing maternal cardiovascular physiology during pregnancy and postpartum","volume":"327","author":"Collins HE","year":"2024","unstructured":"Collins HE, Alexander BT, Care AS, et al.. Guidelines for assessing maternal cardiovascular physiology during pregnancy and postpartum. Am J Physiol Heart Circ Physiol. 2024, 327:H191-220. 10.1152\/ajpheart.00055.2024","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgyn.2007.08.003","article-title":"Pathophysiology of preeclampsia (Article in French)","volume":"37","author":"Tsatsaris V","year":"2008","unstructured":"Tsatsaris V, Fournier T, Winer N. Pathophysiology of preeclampsia (Article in French). J Gynecol Obstet Biol Reprod (Paris). 2008, 37:16-23. 10.1016\/j.jgyn.2007.08.003","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2016.152","article-title":"Pathophysiology of preeclampsia: an angiogenic imbalance and long-lasting systemic vascular dysfunction","volume":"40","author":"Tomimatsu T","year":"2017","unstructured":"Tomimatsu T, Mimura K, Endo M, Kumasawa K, Kimura T. Pathophysiology of preeclampsia: an angiogenic imbalance and long-lasting systemic vascular dysfunction. Hypertens Res. 2017, 40:305-10. 10.1038\/hr.2016.152","journal-title":"Hypertens Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20042994","article-title":"Preeclampsia: recent advances in predicting, preventing, and managing the maternal and fetal life-threatening condition","volume":"20","author":"Chang KJ","year":"2023","unstructured":"Chang KJ, Seow KM, Chen KH. Preeclampsia: recent advances in predicting, preventing, and managing the maternal and fetal life-threatening condition. Int J Environ Res Public Health. 2023, 20:16-8. 10.3390\/ijerph20042994","journal-title":"Int J Environ Res Public Health"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1520218","article-title":"Secondary prevention of preeclampsia","volume":"13","author":"Aldika Akbar MI","year":"2025","unstructured":"Aldika Akbar MI, Rosaudyn R, Gumilar KE, Shanmugalingam R, Dekker G. Secondary prevention of preeclampsia. Front Cell Dev Biol. 2025, 13:1520218. 10.3389\/fcell.2025.1520218","journal-title":"Front Cell Dev Biol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.15394","article-title":"Recurrence of pre-eclampsia and the risk of future hypertension and cardiovascular disease: a systematic review and meta-analysis","volume":"125","author":"Brouwers L","year":"2018","unstructured":"Brouwers L, van der Meiden-van Roest AJ, Savelkoul C, Vogelvang TE, Lely AT, Franx A, van Rijn BB. Recurrence of pre-eclampsia and the risk of future hypertension and cardiovascular disease: a systematic review and meta-analysis. BJOG. 2018, 125:1642-54. 10.1111\/1471-0528.15394","journal-title":"BJOG"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25147886","article-title":"Behind the curtain of abnormal placentation in pre-eclampsia: from molecular mechanisms to histological hallmarks","volume":"25","author":"Gusella A","year":"2024","unstructured":"Gusella A, Martignoni G, Giacometti C. Behind the curtain of abnormal placentation in pre-eclampsia: from molecular mechanisms to histological hallmarks. Int J Mol Sci. 2024, 25:26-8. 10.3390\/ijms25147886","journal-title":"Int J Mol Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2022.03.048","article-title":"Differences and similarities in endothelial and angiogenic profiles of preeclampsia and COVID-19 in pregnancy","volume":"227","author":"Palomo M","year":"2022","unstructured":"Palomo M, Youssef L, Ramos A, et al.. Differences and similarities in endothelial and angiogenic profiles of preeclampsia and COVID-19 in pregnancy. Am J Obstet Gynecol. 2022, 227:277.e1-277.e16. 10.1016\/j.ajog.2022.03.048","journal-title":"Am J Obstet Gynecol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221810122","article-title":"Effect of endogenic and exogenic oxidative stress triggers on adverse pregnancy outcomes: preeclampsia, fetal growth restriction, gestational diabetes mellitus and preterm birth","volume":"22","author":"Joo EH","year":"2021","unstructured":"Joo EH, Kim YR, Kim N, Jung JE, Han SH, Cho HY. Effect of endogenic and exogenic oxidative stress triggers on adverse pregnancy outcomes: preeclampsia, fetal growth restriction, gestational diabetes mellitus and preterm birth. Int J Mol Sci. 2021, 22:23-5. 10.3390\/ijms221810122","journal-title":"Int J Mol Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0265717","article-title":"Placental lesions and differential expression of pro-and anti-angiogenic growth mediators and oxidative DNA damage marker in placentae of Ghanaian suboptimal and optimal health status pregnant women who later developed preeclampsia","volume":"17","author":"Anto EO","year":"2022","unstructured":"Anto EO, Coall DA, Asiamah EA, et al.. Placental lesions and differential expression of pro-and anti-angiogenic growth mediators and oxidative DNA damage marker in placentae of Ghanaian suboptimal and optimal health status pregnant women who later developed preeclampsia. PLoS One. 2022, 17:e0265717. 10.1371\/journal.pone.0265717","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.115314","article-title":"Immunological dysregulation in preeclampsia: pathogenesis and clinical implications","volume":"163","author":"Qin Z","year":"2025","unstructured":"Qin Z, Long Y. Immunological dysregulation in preeclampsia: pathogenesis and clinical implications. Int Immunopharmacol. 2025, 163:115314. 10.1016\/j.intimp.2025.115314","journal-title":"Int Immunopharmacol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2014.102","article-title":"Pre-eclampsia part 1: current understanding of its pathophysiology","volume":"10","author":"Chaiworapongsa T","year":"2014","unstructured":"Chaiworapongsa T, Chaemsaithong P, Yeo L, Romero R. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol. 2014, 10:466-80. 10.1038\/nrneph.2014.102","journal-title":"Nat Rev Nephrol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2016.09.086","article-title":"Should we recommend universal aspirin for all pregnant\u00a0women?","volume":"216","author":"Mone F","year":"2017","unstructured":"Mone F, Mulcahy C, McParland P, McAuliffe FM. Should we recommend universal aspirin for all pregnant\u00a0women?. Am J Obstet Gynecol. 2017, 216:141.e1-5. 10.1016\/j.ajog.2016.09.086","journal-title":"Am J Obstet Gynecol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-016-0630-1","article-title":"Aspirin use in women: current perspectives and future directions","volume":"18","author":"Sarma A","year":"2016","unstructured":"Sarma A, Scott NS. Aspirin use in women: current perspectives and future directions. Curr Atheroscler Rep. 2016, 18:74. 10.1007\/s11883-016-0630-1","journal-title":"Curr Atheroscler Rep"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2021.08.004","article-title":"A randomized controlled trial of low-dose aspirin for the prevention of preeclampsia in women at high risk in China","volume":"226","author":"Lin L","year":"2022","unstructured":"Lin L, Huai J, Li B, et al.. A randomized controlled trial of low-dose aspirin for the prevention of preeclampsia in women at high risk in China. Am J Obstet Gynecol. 2022, 226:251.e1-251.e12. 10.1016\/j.ajog.2021.08.004","journal-title":"Am J Obstet Gynecol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.281388","article-title":"Aspirin in essential thrombocythemia. For whom? What formulation? What regimen?","volume":"108","author":"Cattaneo M","year":"2023","unstructured":"Cattaneo M. Aspirin in essential thrombocythemia. For whom? What formulation? What regimen?. Haematologica. 2023, 108:1487-99. 10.3324\/haematol.2022.281388","journal-title":"Haematologica"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0823-0","article-title":"Aspirin for prevention of preeclampsia","volume":"77","author":"Atallah A","year":"2017","unstructured":"Atallah A, Lecarpentier E, Goffinet F, Doret-Dion M, Gaucherand P, Tsatsaris V. Aspirin for prevention of preeclampsia. Drugs. 2017, 77:1819-31. 10.1007\/s40265-017-0823-0","journal-title":"Drugs"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.14781","article-title":"Aspirin use to prevent preeclampsia and related morbidity and mortality: US Preventive Services Task Force recommendation statement","volume":"326","author":"Davidson KW","year":"2021","unstructured":"Davidson KW, Barry MJ, Mangione CM, et al.. Aspirin use to prevent preeclampsia and related morbidity and mortality: US Preventive Services Task Force recommendation statement. JAMA. 2021, 326:1186-91. 10.1001\/jama.2021.14781","journal-title":"JAMA"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/jbi\/wbae028","article-title":"USPSTF recommendations and overdiagnosis","volume":"6","author":"Hendrick RE","year":"2024","unstructured":"Hendrick RE, Monticciolo DL. USPSTF recommendations and overdiagnosis. J Breast Imaging. 2024, 6:338-46. 10.1093\/jbi\/wbae028","journal-title":"J Breast Imaging"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1172\/JCI91300","article-title":"Prevention of preeclampsia","volume":"126","author":"Grotegut CA","year":"2016","unstructured":"Grotegut CA. Prevention of preeclampsia. J Clin Invest. 2016, 126:4396-8. 10.1172\/JCI91300","journal-title":"J Clin Invest"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1515\/med-2022-0560","article-title":"Monitoring hypertensive disorders in pregnancy to prevent preeclampsia in pregnant women of advanced maternal age: trial mimicking with retrospective data","volume":"17","author":"Deng Y","year":"2022","unstructured":"Deng Y, She L, Li X, et al.. Monitoring hypertensive disorders in pregnancy to prevent preeclampsia in pregnant women of advanced maternal age: trial mimicking with retrospective data. Open Med (Wars). 2022, 17:1840-8. 10.1515\/med-2022-0560","journal-title":"Open Med (Wars)"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000005761","article-title":"Antenatal corticosteroid administration for patients at risk for late preterm delivery: shared decision-making, individualizing risk, and centering patient values","volume":"144","author":"Osmundson SS","year":"2024","unstructured":"Osmundson SS, Lappen JR. Antenatal corticosteroid administration for patients at risk for late preterm delivery: shared decision-making, individualizing risk, and centering patient values. Obstet Gynecol. 2024, 144:744-6. 10.1097\/AOG.0000000000005761","journal-title":"Obstet Gynecol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2024.05.012","article-title":"Update on preeclampsia and hypertensive disorders of pregnancy","volume":"53","author":"Rosenberg EA","year":"2024","unstructured":"Rosenberg EA, Seely EW. Update on preeclampsia and hypertensive disorders of pregnancy. Endocrinol Metab Clin North Am. 2024, 53:377-89. 10.1016\/j.ecl.2024.05.012","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13082442","article-title":"Changes in maternal heart rate variability and photoplethysmography morphology after corticosteroid administration: a prospective, observational study","volume":"13","author":"Bester M","year":"2024","unstructured":"Bester M, Nichting TJ, Joshi R, et al.. Changes in maternal heart rate variability and photoplethysmography morphology after corticosteroid administration: a prospective, observational study. J Clin Med. 2024, 13:4-6. 10.3390\/jcm13082442","journal-title":"J Clin Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2024.06.014","article-title":"AGA clinical practice update on pregnancy-related gastrointestinal and liver disease: expert review","volume":"167","author":"Kothari S","year":"2024","unstructured":"Kothari S, Afshar Y, Friedman LS, Ahn J. AGA clinical practice update on pregnancy-related gastrointestinal and liver disease: expert review. Gastroenterology. 2024, 167:1033-45. 10.1053\/j.gastro.2024.06.014","journal-title":"Gastroenterology"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1111\/jch.12541","article-title":"Low-dose aspirin for preventing preeclampsia and its complications: a meta-analysis","volume":"17","author":"Xu TT","year":"2015","unstructured":"Xu TT, Zhou F, Deng CY, Huang GQ, Li JK, Wang XD. Low-dose aspirin for preventing preeclampsia and its complications: a meta-analysis. J Clin Hypertens (Greenwich). 2015, 17:567-73. 10.1111\/jch.12541","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004659.pub3","article-title":"Antiplatelet agents for preventing pre-eclampsia and its complications","volume":"2019","author":"Duley L","year":"2019","unstructured":"Duley L, Meher S, Hunter KE, Seidler AL, Askie LM. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2019, 2019:32-4. 10.1002\/14651858.CD004659.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2020.100184","article-title":"Low-dose aspirin for preeclampsia prevention: efficacy by ethnicity and race","volume":"2","author":"Tolcher MC","year":"2020","unstructured":"Tolcher MC, Sangi-Haghpeykar H, Mendez-Figueroa H, Aagaard KM. Low-dose aspirin for preeclampsia prevention: efficacy by ethnicity and race. Am J Obstet Gynecol MFM. 2020, 2:100184. 10.1016\/j.ajogmf.2020.100184","journal-title":"Am J Obstet Gynecol MFM"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.07.038","article-title":"Does race or ethnicity play a role in the origin, pathophysiology, and outcomes of preeclampsia? An expert review of the literature","volume":"226","author":"Johnson JD","year":"2022","unstructured":"Johnson JD, Louis JM. Does race or ethnicity play a role in the origin, pathophysiology, and outcomes of preeclampsia? An expert review of the literature. Am J Obstet Gynecol. 2022, 226:S876-85. 10.1016\/j.ajog.2020.07.038","journal-title":"Am J Obstet Gynecol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.14939","article-title":"Preeclampsia, the placenta, ethnicity, and social determinants of health","volume":"103","author":"Sugulle M","year":"2024","unstructured":"Sugulle M. Preeclampsia, the placenta, ethnicity, and social determinants of health. Acta Obstet Gynecol Scand. 2024, 103:1686-8. 10.1111\/aogs.14939","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.40674","article-title":"The intersection of nativity with race and ethnicity in preeclampsia-broadening the assessment of social determinants of maternal health","volume":"4","author":"Shah NS","year":"2021","unstructured":"Shah NS, Kershaw KN, Khan SS. The intersection of nativity with race and ethnicity in preeclampsia-broadening the assessment of social determinants of maternal health. JAMA Netw Open. 2021, 4:e2140674. 10.1001\/jamanetworkopen.2021.40674","journal-title":"JAMA Netw Open"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2022.08.004","article-title":"Clinical factors associated with preeclampsia recurrence","volume":"30","author":"Wainstock T","year":"2022","unstructured":"Wainstock T, Sheiner E. Clinical factors associated with preeclampsia recurrence. Pregnancy Hypertens. 2022, 30:31-5. 10.1016\/j.preghy.2022.08.004","journal-title":"Pregnancy Hypertens"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2017.0023","article-title":"CGM, pregnancy, and remote monitoring","volume":"19","author":"Polsky S","year":"2017","unstructured":"Polsky S, Garcetti R. CGM, pregnancy, and remote monitoring. Diabetes Technol Ther. 2017, 19:S49-59. 10.1089\/dia.2017.0023","journal-title":"Diabetes Technol Ther"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1007\/s43032-020-00207-5","article-title":"Preeclampsia in different maternal age groups-is there an association with pregnancy outcomes and placental pathology?","volume":"27","author":"Bustan-Nahumson M","year":"2020","unstructured":"Bustan-Nahumson M, Bornstein S, Feldstein O, et al.. Preeclampsia in different maternal age groups-is there an association with pregnancy outcomes and placental pathology?. Reprod Sci. 2020, 27:1879-87. 10.1007\/s43032-020-00207-5","journal-title":"Reprod Sci"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1694794","article-title":"Maternal age and preeclampsia outcomes during delivery hospitalizations","volume":"37","author":"Sheen JJ","year":"2020","unstructured":"Sheen JJ, Huang Y, Andrikopoulou M, Wright JD, Goffman D, D'Alton ME, Friedman AM. Maternal age and preeclampsia outcomes during delivery hospitalizations. Am J Perinatol. 2020, 37:44-52. 10.1055\/s-0039-1694794","journal-title":"Am J Perinatol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(01)01733-1","article-title":"Preeclampsia in multiple gestation: the role of assisted reproductive technologies","volume":"99","author":"Lynch A","year":"2002","unstructured":"Lynch A. Preeclampsia in multiple gestation: the role of assisted reproductive technologies. Obstet Gynecol. 2002, 99:445-51. 10.1016\/S0029-7844(01)01733-1","journal-title":"Obstet Gynecol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1570381","article-title":"Prevention of preeclampsia with aspirin in multiple gestations: a systematic review and meta-analysis","volume":"33","author":"Bergeron TS","year":"2016","unstructured":"Bergeron TS, Roberge S, Carpentier C, Sibai B, McCaw-Binns A, Bujold E. Prevention of preeclampsia with aspirin in multiple gestations: a systematic review and meta-analysis. Am J Perinatol. 2016, 33:605-10. 10.1055\/s-0035-1570381","journal-title":"Am J Perinatol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1329691","article-title":"Risks for preeclampsia and small for gestational age: predictive values of placental growth factor, soluble fms-like tyrosine kinase-1, and inhibin A in singleton and multiple-gestation pregnancies","volume":"30","author":"Boucoiran I","year":"2013","unstructured":"Boucoiran I, Thissier-Levy S, Wu Y, et al.. Risks for preeclampsia and small for gestational age: predictive values of placental growth factor, soluble fms-like tyrosine kinase-1, and inhibin A in singleton and multiple-gestation pregnancies. Am J Perinatol. 2013, 30:607-12. 10.1055\/s-0032-1329691","journal-title":"Am J Perinatol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.3390\/nu14091900","article-title":"Vitamin D: before, during and after pregnancy: effect on neonates and children","volume":"14","author":"Mansur JL","year":"2022","unstructured":"Mansur JL, Oliveri B, Giacoia E, Fusaro D, Costanzo PR. Vitamin D: before, during and after pregnancy: effect on neonates and children. Nutrients. 2022, 14:23-5. 10.3390\/nu14091900","journal-title":"Nutrients"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S536497","article-title":"Gaps in low-dose aspirin use for preeclampsia prevention: insights and clinical implications","volume":"17","author":"Ganem N","year":"2025","unstructured":"Ganem N, Frank Wolf M, Kayal RS, Aiob A, Gumin D, Lowenstein L, Sgayer I. Gaps in low-dose aspirin use for preeclampsia prevention: insights and clinical implications. Int J Womens Health. 2025, 17:2909-17. 10.2147\/IJWH.S536497","journal-title":"Int J Womens Health"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15020233","article-title":"Maternal uterine artery Doppler and serum marker in the first trimester as predictive markers for small for gestational age neonates and preeclampsia: a pilot study","volume":"15","author":"Lee JY","year":"2025","unstructured":"Lee JY, Lee KA, Park SY, Kim SJ, Shim SY, Kim YJ, Park MH. Maternal uterine artery Doppler and serum marker in the first trimester as predictive markers for small for gestational age neonates and preeclampsia: a pilot study. Diagnostics (Basel). 2025, 15:16-8. 10.3390\/diagnostics15020233","journal-title":"Diagnostics (Basel)"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00860","article-title":"Influence of polymorphisms involved in platelet activation and inflammatory response on aspirin-related upper gastrointestinal bleeding: a case-control study","volume":"11","author":"Mallah N","year":"2020","unstructured":"Mallah N, Zapata-Cachafeiro M, Aguirre C, et al.. Influence of polymorphisms involved in platelet activation and inflammatory response on aspirin-related upper gastrointestinal bleeding: a case-control study. Front Pharmacol. 2020, 11:860. 10.3389\/fphar.2020.00860","journal-title":"Front Pharmacol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.124.325699","article-title":"Pharmacogenomics and pharmacokinetics of aspirin in preeclampsia prevention","volume":"137","author":"Tlaye KG","year":"2025","unstructured":"Tlaye KG, Woldeamanuel GG, Wong KC, et al.. Pharmacogenomics and pharmacokinetics of aspirin in preeclampsia prevention. Circ Res. 2025, 137:69-82. 10.1161\/CIRCRESAHA.124.325699","journal-title":"Circ Res"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-021-06349-4","article-title":"The role of aspirin dose and initiation time in the prevention of preeclampsia and corresponding complications: a meta-analysis of RCTs","volume":"305","author":"Yip KC","year":"2022","unstructured":"Yip KC, Luo Z, Huang X, et al.. The role of aspirin dose and initiation time in the prevention of preeclampsia and corresponding complications: a meta-analysis of RCTs. Arch Gynecol Obstet. 2022, 305:1465-79. 10.1007\/s00404-021-06349-4","journal-title":"Arch Gynecol Obstet"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1080\/10641955.2022.2046050","article-title":"Letter by Lu et al regarding article, \"the role of aspirin dose and initiation time in the prevention of preeclampsia and corresponding complications: a meta-analysis of RCTs\"","volume":"41","author":"Deng Z","year":"2022","unstructured":"Deng Z, Wang X, Lu D. Letter by Lu et al regarding article, \"the role of aspirin dose and initiation time in the prevention of preeclampsia and corresponding complications: a meta-analysis of RCTs\". Hypertens Pregnancy. 2022, 41:97-8. 10.1080\/10641955.2022.2046050","journal-title":"Hypertens Pregnancy"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/429940-prophylaxis-of-preeclampsia-with-low-dose-aspirin-a-comprehensive-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T07:19:23Z","timestamp":1762845563000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/429940-prophylaxis-of-preeclampsia-with-low-dose-aspirin-a-comprehensive-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":55,"URL":"https:\/\/doi.org\/10.7759\/cureus.96529","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,10]]}}}